Helicobacter pylori cell surface, enzymes, and membranes (H. pylori targets)

Helicobacter pylori cell surface, enzymes, and membranes represent a broad category of therapeutic targets within the Gram-negative bacterium H. pylori, which is a primary cause of chronic gastritis and peptic ulcers (StatPearls, 2023). Key enzymatic targets include urease, which neutralizes gastric acid to facilitate colonization, and various proteins involved in cell wall synthesis and DNA replication (NIH, 2022). The cell surface features adhesins like BabA and SabA that allow the bacteria to persist in the gastric mucosa despite peristalsis (PubMed, 2021). Pharmacological intervention typically involves a combination of antibiotics such as amoxicillin and clarithromycin, which target the cell wall and protein synthesis respectively, often paired with bismuth or proton pump inhibitors (Mayo Clinic, 2023). This target group is clinically significant as H. pylori is classified as a Group 1 carcinogen by the WHO due to its strong association with gastric adenocarcinoma and MALT lymphoma (WHO, 2020). The primary challenge in targeting these components is the increasing prevalence of multi-drug resistant strains, which significantly reduces the efficacy of standard triple and quadruple therapies (Nature Reviews Gastroenterology & Hepatology, 2022). Effective management requires accurate diagnosis through biomarkers like the urea breath test and stool antigen assays (NIH, 2022). Future therapeutic directions include the development of vaccines and novel small molecules that specifically inhibit virulence factors like the CagA secretion system (PubMed, 2021).

Other names

Helicobacter pyloriH. pylori cellular componentsGastric Helicobacter targets

Drugs targeting these components act through various mechanisms: beta-lactams inhibit cell wall synthesis; macrolides and tetracyclines inhibit protein synthesis by binding to the ribosome; fluoroquinolones inhibit DNA gyrase; and bismuth compounds exert multi-targeted antimicrobial effects including enzyme inhibition and membrane disruption.